- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Podcast: This Week in Managed Care—Executive Order to Lower Drug Prices and Other Health News
Every week, The American Journal of Managed Care® recaps the top managed care news of the week.
This week, the top managed care news included top pharmaceutical executives refuse to attend a Trump meeting after executive orders on costs; a survey shows concerns about reopening schools, toll of COVID-19 split by party lines, background; a review of 20 years of data concludes vaccines are "remarkably safe."
Listen above or through one of these podcast services:
Read more about the stories in this podcast:
Trump Signs 4 Executive Orders in Effort to Carry Out Promise to Lower Drug Prices
Concerns About Reopening Schools, Toll of COVID-19 Split by Party Lines, Background
Review of 20 Years of Data Concludes Vaccines Are "Remarkably Safe"
FDA Gives Truvian Emergency OK for Rapid COVID-19 Antibody Test
Effects of a Community-Based Care Management Model for Super-Utilizers
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
